Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cost-effectiveness of Corifollitropin Alfa vs rFSH/HP-hMG in Oocyte Donors
NCT02213627Phase 4Unknown
- Sponsor
- International Vaccine Institute
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of corifollitropin alfa in infertility, sponsored by International Vaccine Institute. Status: unknown.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02213627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213627.